Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 281
Selected: 0
NCT IDTitle
NCT05902559Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
NCT00552149Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
NCT03519048Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma
NCT01504815Adaptive Radiation Treatment for Head and Neck Cancer
NCT02215720Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors
NCT03982173Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors
NCT01112254Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer
NCT00180960Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia
NCT03984318Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NCT03982121Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy
NCT01960751Long Term Neurocognitive Effects of Low-dose Radiation in the Brain: Study of 150 Patients in the French Hemangioma Cohort
NCT03244956Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer
NCT00367861Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance
NCT05874063Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
NCT04932525Gustave Roussy Cancer Profiling
NCT06957132Analysis of Risk Factors for Hearing Loss in Survivors of Cancer Occurred During Childhood, Adolescence or Young Adulthood
NCT02233049Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
NCT00920920An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer
NCT01180335Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer
NCT04224389IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
NCT04304924Motivating to Exercise and Diet, and Educating to Healthy Behaviors After Breast Cancer
NCT06781996A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer
NCT00852228Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy
NCT00126230Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer
NCT07016230Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
NCT02260739Sequential Analysis in Patients With an Hemopathy
NCT01837745Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
NCT06712472Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer
NCT05705791Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NCT05947903Validation of the European Oncology Quality of Life Toolkit
NCT03212651Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab
NCT06364631CARE1 Pragmatic Clinical Trial
NCT02831530Randomized Short-term Pre-surgical Study to Assess the Effects of Abemaciclib (LY2835219) in Early Breast Cancer Patients
NCT03803735Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa
NCT02105168Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02044354Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer
NCT02997384Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT03819101Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer
NCT05215106Short-term Pre-OPerative Durvalumab (MEDI 4736) in Early Small Triple Negative Breast Cancer Patients (POP-Durva)
NCT05481502An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
NCT00162669Bevacizumab in Advanced Hepatocellular Carcinoma
NCT05476939Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
NCT01464086LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)
NCT03983369Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults
NCT05977062Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With Insomnia
NCT01226394Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients
NCT01289522Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT01786031Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
NCT04953312Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)
NCT03596281Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer